alterntif text

Sirtex shares dive on lower sales forecast



shares in the treatment of developer cancer medical Sirtex after it lowered its sales outlook .

the company expects sales of the product leadership, SIR- balls Y-0 resin microspheres, to rise by between 15 and 17 per cent in the financial year 2015/16.

this and apos; s weaker than the average growth of 19.7 percent achieved in the previous five years


Sirtex product is targeted radiation therapy for liver cancer sales. it was weaker than expected in Europe and the Middle East, Africa, Asia and the Pacific, which offset strong growth in the Americas.

crashes temporary supply, delays in the payment of the product later than the expected publication of clinical study, he said in a medical journal affected the sales of the

company made. And decreased the company’s shares $ 2.26, or 7.2 percent, to $ 29.24

“While we are disappointed that we will be able to achieve our CEO Gilman Wong said guidance FY16 sales dose of growth, it is important to be aware the effects of the business outside of the Americas and timing-related. ”

charts market at 11:21

switch planning points change ratio
Hang Seng 20815.09 0.0 0.0
Hang Seng daily chart
ASX200 5315.6 -63.0 -1.17
ASX200 daily chart
All Ords 5388.9 -58.9 -1.08
All Ords daily chart
Nikki 17089.69 -145.29 -0.84
Nikkei daily chart
switch to the planning points change ratio
Dow Jones industrial Average 0.0 0.0
DJIA daily chart
S & P 500 2096.96 -2.1 -0.1
S&P 500 daily chart
S & P 100 575.64 – 10:07 -1.72
S&P 100 daily chart
Nasdaq 4948.05 14.55 0.29
NASDAQ daily chart
switch to the planning points change ratio
CAC 40 4505.62 -23.78 -0.53
CAC 40 daily chart
DAX 30 10262.74 -70.49 -0.68
DAX 30 daily chart
FTSE 6230.79 -40.0 -0.64
FTSE daily chart
euro TOP100 2679.94 -24.82 -0.92
Euro Top100 daily chart
switch to the planning points change ratio
AUD / USD 0.932 0.0 0.2
AUD/USD daily chart
switch to the planning points change ratio
oil 49.1 -0.23 -0.47
Oil daily chart

Mozo-powered credit card, home loan and savings comparisons
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


To Top